Option chain shows key data for Fractyl Health's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Fractyl Health.

Fractyl Health (NASDAQ:GUTS) Stock, Option Chain

Fractyl Health

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACOR

BCAN

CALM

CISS

EDBL

GMDA

GUTS

INTC

LGVC

MESO

MOTS

ONMD

PLAY

SINT

VIEW

VNDA

VVPR

Shares of  Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter.

Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

NKLA

NUVB

XPEV

U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday.

Intel, XPeng And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

Intraday Update

ACON

ADTX

ALLG

ASTS

AVTX

AWIN

CIFR

CLSK

CXAI

DCFC

GCTS

GOEV

GRTS

JZXN

LIFW

MSTR

MVST

ORGS

PPSI

PTPI

QDEL

SIGA

SNAX

TPET

VERV

VTSI

XTIA

YTEN

Shares of  Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Fractyl Health Inc

Health Care

Press Releases

Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024

Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024

Earnings

Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates

Fractyl Health to Participate in the Upcoming December Conferences

Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort

Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025

Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025

Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Apyx Medical

HeartBeam

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

CytoSorbents

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Fractyl Health

Fractyl Health (GUTS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga